Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 57

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 57
---
 ​           | ​ |       14,480 | (2)  ​ |   |    2,573,096 |
| ​                  | ​ |           78,559 | ​ |             — | ​      |            |  93.5000 | ​ | 2/19/2030  | ​ | ​ | ​            | ​ | ​           | ​ |       20,994 | (2)  ​ |   |    3,730,634 |
| ​                  | ​ |           42,236 | ​ |             — | ​      |            | 105.9200 | ​ | 2/17/2031  | ​ | ​ | ​            | ​ | ​           | ​ |            — | ​      |   |            — |
| ​                  | ​ |           23,351 | ​ |        11,675 | (2)  ​ |            | 144.5400 | ​ | 2/16/2032  | ​ | ​ | ​            | ​ | ​           | ​ |            — | ​      |   |            — |
| ​                  | ​ |            7,315 | ​ |        14,629 | (2)  ​ |            | 149.6200 | ​ | 2/15/2033  | ​ | ​ | ​            | ​ | ​           | ​ |            — | ​      |   |            — |
| ​                  | ​ |                — | ​ |        28,998 | (2)  ​ |            | 175.2800 | ​ | 2/14/2034  | ​ | ​ | ​            | ​ | ​           | ​ |            — | ​      |   |            — |

| (1) | Except as noted, the stock options are fully vested. |

2025 Proxy Statement |57

| ​                      | ​ |
| EXECUTIVE COMPENSATION | ​ |

| (2) | The vesting dates of AbbVie unexercisable stock options and unvested performance share and restricted stock unit awards outstanding at December 31, 2024 are as follows: |

| ​                  | ​ |             ​ | ​ | ​             | ​ | ​             | ​ | ​             | ​ | ​ |                    ​ | ​ | ​             |
| ​                  | ​ | Option Awards |   |               |   |               |